SOURCE: Entelos, Inc.

July 06, 2005 08:00 ET

Entelos Announces Expanded Hematology Collaboration With Johnson & Johnson Pharmaceutical Research & Development

FOSTER CITY, CA -- (MARKET WIRE) -- July 6, 2005 -- Entelos, Inc., the leader in biosimulation technologies for pharmaceutical research and development, announced today that Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) has expanded its research collaboration in hematology. In this expanded effort, Entelos will investigate the effect of anti-anemia therapy on patients with different types of anemia, explore the impact of patient variability, and provide guidance on optimization of anemia clinical trials.

In January 2004, Entelos and J&JPRD agreed to collaborate in developing the Hematopoiesis PhysioLab® platform. The companies have applied this technology to a range of research objectives related to various projects at J&JPRD.

"Entelos is extremely pleased to announce the continuation and expansion of this research collaboration," stated James Karis, President and CEO of Entelos. "This extension demonstrates that Entelos technology is having a significant impact in supportive care."

About Entelos

Entelos, Inc. ( is a biopharmaceutical company focused on discovering and developing new therapies for metabolic and inflammatory disorders. Our mission is to leverage our unique predictive capability in human biology to dramatically improve how medicines are discovered, developed, and brought to market. Using our proprietary PhysioLab biosimulation platforms -- computer-based mathematical models of human disease, we systematically uncover the biological mechanisms underlying a disease in order to identify potential points of therapeutic intervention and the patients most likely to benefit. In addition to our internal research programs, Entelos partners with pharmaceutical and biotechnology organizations worldwide.

Entelos is a registered trademark of Entelos, Inc. PhysioLab is a trademark and service mark of Entelos, Inc.

Contact Information

  • Contacts:
    Entelos, Inc.
    Barry Sudbeck
    Email Contact

    McKinney Chicago
    Alan Zachary
    Email Contact
    +1.312.944.6784 ext. 316